Related Experiment Video
Updated: Dec 12, 2025
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
14.9K
Antiviral effects of statins
Armita M Gorabi1, Nasim Kiaie1, Vanessa Bianconi2
1Research Center for Advanced Technologies in Cardiovascular Medicine, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
Progress in Lipid Research
|August 11, 2020
Summary
Statins show potential for treating viral infections by modulating the immune system and inhibiting viral replication. This review explores their antiviral mechanisms, including cholesterol-dependent and independent pathways.
Area of Science:
- Pharmacology
- Virology
- Immunology
Background:
- Statins are widely prescribed cholesterol-lowering drugs.
- Emerging evidence suggests statins possess antiviral properties.
- Their potential in treating viral infections warrants comprehensive review.
Purpose of the Study:
- To review the antiviral properties of statins.
- To explore statins' immunomodulatory effects in viral infections.
- To detail statins' inhibition of viral replication and transmission.
Main Methods:
- Literature review of experimental and clinical studies.
- Analysis of data on statin-host immune interactions.
- Examination of statins' effects on viral cell cycle stages.
Main Results:
- Statins exhibit antiviral effects through immunomodulation.
- They inhibit viral replication at various stages of the virus life cycle.
- Both cholesterol-dependent and independent mechanisms are implicated.
Conclusions:
- Statins may serve as accessible therapeutic agents for viral infections.
- Further research is needed to fully elucidate their antiviral potential.
- Statins' dual action on immunity and viral replication is promising.
More Related Videos
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.2K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.2K
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
136
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
136
01:10Retrovirus Life Cycles
48.9K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
48.9K
02:33Retroviruses
14.4K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
14.4K
01:25Pharmacokinetics: Drug–Drug Interactions
225
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
225
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
106
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
106